C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2006
12/07/2006	US20060276470 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy
12/07/2006	US20060276456 Such as [1,1-biphenyl]-4-yl-(5,11-dihydro-10H-dibenzo[b,e][1,4]diazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia
12/07/2006	US20060273819 Antibiotic tetrahydro-beta-carboline derivatives
12/07/2006	CA2611134A1 New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation
12/07/2006	CA2610695A1 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system
12/07/2006	CA2609930A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006	CA2609660A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006	CA2609388A1 Novel piperidine derivative
12/07/2006	CA2608916A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006	CA2608212A1 Novel piperidine carboxylic acid amide derivatives
12/06/2006	EP1727820A2 Amine derivatives
12/06/2006	EP1727819A1 Novel dichloro-phenyl-pyrido¬2,3-d\|pyrimidine derivatives, their manufacture and use as pharmaceutical agents
12/06/2006	EP1727818A1 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
12/06/2006	EP1727813A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
12/06/2006	EP1397135B1 Combination of a pde4 inhibitor and tiotropium or derivative thereof for treating obstructive airways
12/06/2006	CN1875021A Substituted naphthyridinone derivatives
12/06/2006	CN1874769A Heterocyclic inhibitors of MEK and methods of use thereof
12/06/2006	CN1288154C Technical synthesis method for producing tropenol
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/05/2006	US7145012 Cannabinoid receptor ligands and uses thereof
12/05/2006	US7145010 Tert-alkylphenoxy-substituted polycyclic compounds
12/05/2006	US7145008 Pyrimidine derivatives for the treatment of abnormal cell growth
12/05/2006	US7144913 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
12/05/2006	US7144907 mitogen activated protein kinase inhibitors such as 6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methylbenzo[d]isoxazole-5-carboxylic acid (2-hydroxyethoxy)-amide, used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals
12/05/2006	US7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
12/05/2006	US7144883 Substituted fused ring sulfonamides containing, e.g., naphthalene, isoquinoline, quinoline, benzofuran or benzothiophene rings; treatment of conditions relating to obesity, type II diabetes and CNS disorders
12/05/2006	US7144882 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
12/05/2006	US7144876 3,5-Disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
12/05/2006	US7144843 For plants; fungicides
12/05/2006	CA2293713C Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase
12/05/2006	CA2245728C Isoquinoline derivatives and drugs
12/05/2006	CA2203078C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]indoles as estrogenic agents
11/2006
11/30/2006	WO2006128120A2 Novel lapachone compounds and methods of use thereof
11/30/2006	WO2006127587A1 Pyrrolopyridines useful as inhibitors of protein kinase
11/30/2006	WO2006127584A1 Imidazolone phenylalanine derivatives as vla-4 antagonists
11/30/2006	WO2006126083A1 Pyridine [3 , 4-b] pyrazinone compounds as pde-5 inhibitors
11/30/2006	WO2006126082A2 Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
11/30/2006	WO2006126081A2 Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
11/30/2006	WO2006125974A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
11/30/2006	WO2006125958A1 2-phenyl substituted imidazol [4 , 5b] pyridine/ pyrazine and purine derivatives as glucokinase modulators
11/30/2006	WO2006125887A1 5h-pyrido[4,3-b]indole derivative compounds and uses thereof as medicine for treating polyglutamin neurodegenerative diseases
11/30/2006	WO2006125324A1 Treatment of protein folding disorders
11/30/2006	WO2006037748A8 Substituted tricyclic benzimidazoles
11/30/2006	US20060270880 7-Azaindole derivatives as cox2 inhibitors
11/30/2006	US20060270853 Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one useful in the preparation of the DPP-IV inhibitor (S)-1 ((2S,3S,11bS)-2-amino-9,10-dimethoxy-1,3,4,6,7, 11b-hexahydro-2h-pyrido[2,1-a] isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one
11/30/2006	US20060270846 Synthons; nanomembranes
11/30/2006	US20060270729 Agents useful for reducing amylioid precursor protein and treating dementia and methods of use thereof
11/30/2006	US20060270702 Certain substituted ureas, as modulators of kinase activity
11/30/2006	US20060270701 Dipeptidyl peptidase-IV inhibitors
11/30/2006	US20060270689 Novel Fused Heterocycles and Uses Thereof
11/30/2006	US20060270687 Such as n-(4-fluorobenzyl)-6-(4-methyl-1H-imidazol-1-yl)pyrazin-2-amine; protein kinase associated disease states
11/30/2006	US20060270654 1,6-Dihydro-1,3,5,6-Tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
11/30/2006	US20060270653 such as 1-(1'-(1-methylcyclohexyl)-1H-spiro[isoquinoline-4,4'-piperidine]-2(3H)-yl)ethanone, used for the treatment of vision defects, nervous system, psychological, gastrointestinal, genetic and muscular disorders, or as wound healing agents
11/30/2006	US20060270646 Jnk inhibitors
11/30/2006	US20060269956 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
11/30/2006	US20060269855 Polycarbonates, polyesters and polyimides from the dimers exhibit properties of both binders and an electron-transporting materials; electrographic and photoconductor elements
11/30/2006	US20060269487 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/30/2006	CA2609980A1 Treatment of protein folding disorders
11/30/2006	CA2609270A1 Hydantoin compounds
11/30/2006	CA2609126A1 Pyrrolopyridines useful as inhibitors of protein kinase
11/30/2006	CA2608672A1 Pyridine [3,4-b] pyrazinones as pde-5 inhibitors
11/30/2006	CA2608072A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
11/29/2006	EP1726590A1 Cycloalkanopyridine derivative
11/29/2006	EP1726585A1 Diaryl-substituted five-membered heterocycle derivative
11/29/2006	EP1725569A1 Prodrugs of piperazine and substituted piperidine antiviral agents
11/29/2006	EP1725567A1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor
11/29/2006	EP1725556A1 Hiv integrase inhibitors
11/29/2006	EP1725555A1 Pyrrolopyridine-2-carboxylic acid hydrazides as inhibitors of glycogen phosphorylase
11/29/2006	EP1725554A1 Hiv integrase inhibitors
11/29/2006	EP1725553A1 Tetrahydropyridoindole derivatives
11/29/2006	EP1725543A1 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
11/29/2006	EP1725535A2 Hiv integrase inhibitors
11/29/2006	EP1725534A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
11/29/2006	EP1725531A2 Inhibitors of dna methylation in tumor cells
11/29/2006	EP1725415A1 Steering and driving system for an industrial truck
11/29/2006	EP1725239A1 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
11/29/2006	EP1725235A1 Piperidine derivatives useful as ccr3 antagonists
11/29/2006	EP1553947A4 Quinazolinones and derivatives thereof as factor xa inhibitors
11/29/2006	CN1871516A Combining identifying method of labeled bridged dipiperidine
11/29/2006	CN1871238A Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
11/29/2006	CN1871237A 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors
11/29/2006	CN1871236A Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders
11/29/2006	CN1871233A Novel chelating agents and chelates and their use
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871008A Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
11/29/2006	CN1870998A Ccr－2拮抗剂盐 Ccr-2 antagonist salt
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1870896A Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
11/29/2006	CN1869036A 7-substituted-3-chloro pyrrolo [3,4-b] pyridine compound
11/29/2006	CN1286831C N-ureido-piperidines as antagonists viii for CCR-3 receptor
11/29/2006	CN1286810C 2-acyl indol derivatives and their use as anti-tumour agents
11/28/2006	US7141671 Biphenyl derivatives
11/28/2006	US7141669 Cannabiniod receptor ligands and uses thereof
11/28/2006	US7141598 Imidazole derivatives, production method thereof and use thereof
11/28/2006	US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141579 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
11/28/2006	US7141578 For treating cancer, cardiovascular, sexual and immune disorders; 3a alpha ,4 beta ,5 alpha ,7 beta ,7a alpha )-4-(Octahydro-5- ethylsulfonamido-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2- (trifluoromethyl)benzonitrile
11/28/2006	US7141574 Viral polymerase inhibitors

1 ... 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 ... 646